Recro Pharma
REPH
#9059
Rank
โ‚ฌ0.10 B
Marketcap
1,80ย โ‚ฌ
Share price
-0.48%
Change (1 day)
-35.05%
Change (1 year)

Revenue for Recro Pharma (REPH)

Revenue in 2021 (TTM): โ‚ฌ64.97 Million

According to Recro Pharma 's latest financial reports the company's current revenue is โ‚ฌ64.72 Million. In 2020 the company made a revenue of โ‚ฌ57.11 Million a decrease over the revenue in the year 2019 that were of โ‚ฌ85.21 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Recro Pharma from 2016 to 2021

Annual revenue

Year Revenue Change
2021 (TTM)โ‚ฌ64.97 M13.75%
2020โ‚ฌ57.11 M-32.98%
2019โ‚ฌ85.21 M28.28%
2018โ‚ฌ66.43 M7.67%
2017โ‚ฌ61.69 M3.6%
2016โ‚ฌ59.55 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ79.14 B 122,178.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
โ‚ฌ86.23 M 33.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
โ‚ฌ0.61 B 851.16%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
โ‚ฌ0.55 M-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
โ‚ฌ6.12 M-90.53%๐Ÿ‡บ๐Ÿ‡ธ USA